in 31 days, so he's in a hurry to get it done today or tomorrow.
I'm in Florida right now and heard three Anatabloc commercials in past week both on regular radio and satellite radio. Best guess - they are TARGETING the best markets - older and more up-scale. Looked like it was in conjunction with GNC (they were mentioned in the commercials) who knows a lot more about marketing than the folks at Star.
Enzo Contract Claims Trimmed In Affymetrix Med Testing Row
Share us on:
By Michael Lipkin 0 Comments
Law360, Los Angeles (December 09, 2013, 6:44 PM ET) -- A New York federal judge on Friday pared most claims from Enzo Biochem Inc.’s suit alleging Affymetrix Inc. had breached a contract allowing it to distribute Enzo’s products for detecting nucleic acids, ruling Enzo had not provided enough information to back the claims up.
U.S. District Judge Richard J. Sullivan partially granted Affymetrix’s motion for summary judgment and tossed three of Enzo’s claims, including a claim that Affymetrix had not used reasonable efforts to sell Enzo’s chemical reagents under the terms of a 1998 distribution agreement....
I assume they saw that 2 highly recognized experts in their fields left high-powered jobs to join Star. They both are in unique positions (board member, and Roskamp Institute) to understand the efficacy of Anatabloc, so why bet against them, especially with the stock down to where they can cover at a profit, and maybe even go long and make money the other direction. There still are 26,000,000 shares to e covered. That's a lot of buying.
These guys are as successful in their fields as one can be. WHY would they risk financial futures and their profound reputations if they didn't KNOW that good things are coming to Star Scientific - soon to Rock Creek Pharmaceutical?
I'm thrilled to be on-board with these chaps.
If you KNOW rosacea, you KNOW how most women who have it (the vast majority affects women) will pay a lot to correct it. The doctors doing the study found 70 % improvement in just a short time and with relatively low doses.
14.000,000 people in the US have rosacea. (Probably triple that outside the US). If just 1,000,000 (7% ) of US suffers bought the anatabloc cream, Star/Rock Creek would have a blockbuster ($1 billion) product and you would be a very happy investor.
Good point, the hedge funds start buying star knowing that as they drive it up, the stock shorts and the Call shorts get screwed and have to cover. The hedge funds can go long knowing the shorts will have to cover and buy stock back from the hedge funds screwing them. Of course I too will play when I see this happening, and I hope it comes sooner, maybe from a company announcement about some corporate (or hospital - Johns Hopkins?) alliance.
As for hedge funds not screwing each other - I know a few, and none of them wouldn't drive over their mothers for a small profit.
Glad I had some extra cash, I'm looking for a 3 - 6 month + 50% and a 12 - 18 month double.
He said, "This is exactly the kind of thing we have been looking for. To me, this is Proof of Concept. The guys that understand anatabine are tying their futures, their financial lives and their reputations to it. What more do you want - IT WORKS!"
I used quotes, but I actually paraphrased him. He said he is adding 40% to his position as funds come in - including Twitter which he just bought on the offering and will "flip?"
just saw that on Fox, what is so disconcerting is that they knew the 90 million back in 2010,It's,. a government estimate, and to think OHO, Reid, Pelosi, Derbin (my senator) Hoyer, etc, THEY ALL FREAKIN KNEW.
He DID lie, he never could have sold his snake oil without lying. It will be s disaster for al, even the super rich because we will lose so many mds.
the first under the much larger Mauldin association
Since he mentioned life - extension and neutricuticals and since he has so much family history with Star Scientific and anatabloc, it should be a good day tomorrow. Mauldin has arguably the biggest following out there.
didn't bother to check company's latest financials which contradict his comments. Nor does he understand the nature of a death spiral investment which he is clearly unqualified to write about. Also, the stock is indicating something big is coming.